Cargando…

Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center

The prognostic significance of the width of the ulceration in primary melanomas remains unclear, and there is a relative paucity of data for lymphovascular invasion (LVI), microscopic satellitosis (MS), perineural invasion (PNI), and mitotic rate when compared with other pathological elements curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Namikawa, Kenjiro, Aung, Phyu P., Gershenwald, Jeffrey E., Milton, Denái R., Prieto, Victor G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852363/
https://www.ncbi.nlm.nih.gov/pubmed/29464914
http://dx.doi.org/10.1002/cam4.1320
_version_ 1783306556796829696
author Namikawa, Kenjiro
Aung, Phyu P.
Gershenwald, Jeffrey E.
Milton, Denái R.
Prieto, Victor G.
author_facet Namikawa, Kenjiro
Aung, Phyu P.
Gershenwald, Jeffrey E.
Milton, Denái R.
Prieto, Victor G.
author_sort Namikawa, Kenjiro
collection PubMed
description The prognostic significance of the width of the ulceration in primary melanomas remains unclear, and there is a relative paucity of data for lymphovascular invasion (LVI), microscopic satellitosis (MS), perineural invasion (PNI), and mitotic rate when compared with other pathological elements currently required for reporting. To evaluate the prognostic importance of the ulceration width and other important pathologic measurements, a single‐institutional retrospective study was conducted using records of cutaneous melanoma patients who underwent sentinel lymph node (SLN) biopsy at The University of Texas, MD Anderson Cancer Center between 2003 and 2008. We identified 1898 eligible patients with median tumor thickness of 1.25 mm and median follow‐up of 6.7 years. By multivariable analyses, the strongest risk factor for SLN positivity was high tumor thickness followed by the presence of LVI. The pathologic measures with the strongest influence on recurrence‐free survival (RFS) were tumor thickness and positive SLN status. Ulceration width and presence of MS were also significantly associated with RFS while PNI was not. Factors with the strongest influence on melanoma‐specific survival (MSS) were positive SLN status and mitotic rate. In conclusion, SLN biopsy should probably be offered if the primary tumor has LVI. MS is an adverse prognostic factor for RFS, but its influence on outcome is modest. Ulceration width predicts RFS but loses its independent prognostic significance for MSS when adjusting for currently used clinicopathological factors. In view of its impact on MSS, mitotic rate should be recorded for cutaneous invasive melanomas across all T categories.
format Online
Article
Text
id pubmed-5852363
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58523632018-03-22 Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center Namikawa, Kenjiro Aung, Phyu P. Gershenwald, Jeffrey E. Milton, Denái R. Prieto, Victor G. Cancer Med Clinical Cancer Research The prognostic significance of the width of the ulceration in primary melanomas remains unclear, and there is a relative paucity of data for lymphovascular invasion (LVI), microscopic satellitosis (MS), perineural invasion (PNI), and mitotic rate when compared with other pathological elements currently required for reporting. To evaluate the prognostic importance of the ulceration width and other important pathologic measurements, a single‐institutional retrospective study was conducted using records of cutaneous melanoma patients who underwent sentinel lymph node (SLN) biopsy at The University of Texas, MD Anderson Cancer Center between 2003 and 2008. We identified 1898 eligible patients with median tumor thickness of 1.25 mm and median follow‐up of 6.7 years. By multivariable analyses, the strongest risk factor for SLN positivity was high tumor thickness followed by the presence of LVI. The pathologic measures with the strongest influence on recurrence‐free survival (RFS) were tumor thickness and positive SLN status. Ulceration width and presence of MS were also significantly associated with RFS while PNI was not. Factors with the strongest influence on melanoma‐specific survival (MSS) were positive SLN status and mitotic rate. In conclusion, SLN biopsy should probably be offered if the primary tumor has LVI. MS is an adverse prognostic factor for RFS, but its influence on outcome is modest. Ulceration width predicts RFS but loses its independent prognostic significance for MSS when adjusting for currently used clinicopathological factors. In view of its impact on MSS, mitotic rate should be recorded for cutaneous invasive melanomas across all T categories. John Wiley and Sons Inc. 2018-02-21 /pmc/articles/PMC5852363/ /pubmed/29464914 http://dx.doi.org/10.1002/cam4.1320 Text en © 2018 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Namikawa, Kenjiro
Aung, Phyu P.
Gershenwald, Jeffrey E.
Milton, Denái R.
Prieto, Victor G.
Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center
title Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center
title_full Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center
title_fullStr Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center
title_full_unstemmed Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center
title_short Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center
title_sort clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852363/
https://www.ncbi.nlm.nih.gov/pubmed/29464914
http://dx.doi.org/10.1002/cam4.1320
work_keys_str_mv AT namikawakenjiro clinicalimpactofulcerationwidthlymphovascularinvasionmicroscopicsatellitosisperineuralinvasionandmitoticrateinpatientsundergoingsentinellymphnodebiopsyforcutaneousmelanomaaretrospectiveobservationalstudyatacomprehensivecancercenter
AT aungphyup clinicalimpactofulcerationwidthlymphovascularinvasionmicroscopicsatellitosisperineuralinvasionandmitoticrateinpatientsundergoingsentinellymphnodebiopsyforcutaneousmelanomaaretrospectiveobservationalstudyatacomprehensivecancercenter
AT gershenwaldjeffreye clinicalimpactofulcerationwidthlymphovascularinvasionmicroscopicsatellitosisperineuralinvasionandmitoticrateinpatientsundergoingsentinellymphnodebiopsyforcutaneousmelanomaaretrospectiveobservationalstudyatacomprehensivecancercenter
AT miltondenair clinicalimpactofulcerationwidthlymphovascularinvasionmicroscopicsatellitosisperineuralinvasionandmitoticrateinpatientsundergoingsentinellymphnodebiopsyforcutaneousmelanomaaretrospectiveobservationalstudyatacomprehensivecancercenter
AT prietovictorg clinicalimpactofulcerationwidthlymphovascularinvasionmicroscopicsatellitosisperineuralinvasionandmitoticrateinpatientsundergoingsentinellymphnodebiopsyforcutaneousmelanomaaretrospectiveobservationalstudyatacomprehensivecancercenter